Eur Rev Med Pharmacol Sci 2018; 22 (5): 1169-1170
DOI: 10.26355/eurrev_201803_14452

Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma

C. D’Aniello, S. Pisconti, S. Facchini, C. Imbimbo, C. Cavaliere

Division of Medical Oncology, A.O.R.N. dei Colli – “Ospedali Monaldi-Cotugno-CTO”, Naples, Italy. carla.cavaliere@hotmail.it

Free PDF Download

To cite this article

C. D’Aniello, S. Pisconti, S. Facchini, C. Imbimbo, C. Cavaliere
Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 5
Pages: 1169-1170
DOI: 10.26355/eurrev_201803_14452

Keywords Related articles:

  1. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma
  2. Long noncoding RNA SNHG15, a potential prognostic biomarker for hepatocellular carcinoma
  3. LASP2 functions as a potential prognostic factor and therapeutic target in nasopharyngeal carcinoma
  4. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer
  5. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis